vs

Side-by-side financial comparison of Carter Bankshares, Inc. (CARE) and Cardlytics, Inc. (CDLX). Click either name above to swap in a different company.

Cardlytics, Inc. is the larger business by last-quarter revenue ($50.9M vs $39.8M, roughly 1.3× Carter Bankshares, Inc.). On growth, Carter Bankshares, Inc. posted the faster year-over-year revenue change (15.4% vs -25.5%). Carter Bankshares, Inc. produced more free cash flow last quarter ($31.8M vs $13.0M). Over the past eight quarters, Carter Bankshares, Inc.'s revenue compounded faster (9.1% CAGR vs -9.6%).

Carter Bankshares, Inc. is a U.S. regional bank holding company operating Carter Bank & Trust, a community-focused financial institution. It offers a full range of retail and commercial banking products including deposit accounts, personal and business loans, and wealth management services, primarily serving consumers and small business clients across Virginia and North Carolina.

Cardlytics is a leading purchase intelligence and advertising platform that partners with major banks to analyze anonymized consumer transaction data. It delivers targeted, performance-driven ad campaigns for consumer brands, retailers and service providers, helping advertisers reach audiences based on real purchase behavior, with core operations across North America and the United Kingdom.

CARE vs CDLX — Head-to-Head

Bigger by revenue
CDLX
CDLX
1.3× larger
CDLX
$50.9M
$39.8M
CARE
Growing faster (revenue YoY)
CARE
CARE
+40.8% gap
CARE
15.4%
-25.5%
CDLX
More free cash flow
CARE
CARE
$18.8M more FCF
CARE
$31.8M
$13.0M
CDLX
Faster 2-yr revenue CAGR
CARE
CARE
Annualised
CARE
9.1%
-9.6%
CDLX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CARE
CARE
CDLX
CDLX
Revenue
$39.8M
$50.9M
Net Profit
Gross Margin
Operating Margin
27.8%
-12.0%
Net Margin
Revenue YoY
15.4%
-25.5%
Net Profit YoY
EPS (diluted)
$0.38
$-0.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CARE
CARE
CDLX
CDLX
Q4 25
$39.8M
$50.9M
Q3 25
$39.1M
$47.0M
Q2 25
$37.3M
$58.0M
Q1 25
$37.0M
$56.4M
Q4 24
$34.5M
$68.3M
Q3 24
$34.2M
$61.1M
Q2 24
$33.6M
$64.0M
Q1 24
$33.5M
$62.2M
Net Profit
CARE
CARE
CDLX
CDLX
Q4 25
Q3 25
$5.4M
$-72.7M
Q2 25
$8.5M
$-9.3M
Q1 25
$9.0M
$-13.3M
Q4 24
Q3 24
$5.6M
$-145.2M
Q2 24
$4.8M
$-4.3M
Q1 24
$5.8M
$-24.3M
Operating Margin
CARE
CARE
CDLX
CDLX
Q4 25
27.8%
-12.0%
Q3 25
18.3%
-146.6%
Q2 25
28.5%
-22.0%
Q1 25
30.1%
-24.9%
Q4 24
31.0%
-12.2%
Q3 24
20.5%
-243.1%
Q2 24
17.6%
-24.7%
Q1 24
21.6%
-36.7%
Net Margin
CARE
CARE
CDLX
CDLX
Q4 25
Q3 25
13.9%
-154.7%
Q2 25
22.8%
-16.0%
Q1 25
24.2%
-23.5%
Q4 24
Q3 24
16.4%
-237.6%
Q2 24
14.3%
-6.7%
Q1 24
17.4%
-39.0%
EPS (diluted)
CARE
CARE
CDLX
CDLX
Q4 25
$0.38
$-0.15
Q3 25
$0.24
$-1.36
Q2 25
$0.37
$-0.18
Q1 25
$0.39
$-0.26
Q4 24
$0.36
$-0.36
Q3 24
$0.24
$-2.90
Q2 24
$0.21
$-0.09
Q1 24
$0.25
$-0.56

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CARE
CARE
CDLX
CDLX
Cash + ST InvestmentsLiquidity on hand
$48.7M
Total DebtLower is stronger
$212.6M
Stockholders' EquityBook value
$419.7M
$-6.5M
Total Assets
$4.9B
$285.6M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CARE
CARE
CDLX
CDLX
Q4 25
$48.7M
Q3 25
$44.0M
Q2 25
$46.7M
Q1 25
$52.0M
Q4 24
$65.6M
Q3 24
$67.0M
Q2 24
$71.2M
Q1 24
$97.8M
Total Debt
CARE
CARE
CDLX
CDLX
Q4 25
$212.6M
Q3 25
$214.6M
Q2 25
$214.3M
Q1 25
$213.9M
Q4 24
$213.6M
Q3 24
$213.2M
Q2 24
$212.9M
Q1 24
$257.9M
Stockholders' Equity
CARE
CARE
CDLX
CDLX
Q4 25
$419.7M
$-6.5M
Q3 25
$412.8M
$-4.7M
Q2 25
$405.6M
$58.7M
Q1 25
$401.8M
$64.1M
Q4 24
$384.3M
$70.0M
Q3 24
$386.8M
$69.7M
Q2 24
$364.4M
$210.0M
Q1 24
$359.1M
$199.1M
Total Assets
CARE
CARE
CDLX
CDLX
Q4 25
$4.9B
$285.6M
Q3 25
$4.8B
$292.8M
Q2 25
$4.8B
$361.1M
Q1 25
$4.7B
$369.1M
Q4 24
$4.7B
$392.7M
Q3 24
$4.6B
$399.4M
Q2 24
$4.5B
$534.4M
Q1 24
$4.6B
$569.0M
Debt / Equity
CARE
CARE
CDLX
CDLX
Q4 25
Q3 25
Q2 25
3.65×
Q1 25
3.34×
Q4 24
3.05×
Q3 24
3.06×
Q2 24
1.01×
Q1 24
1.29×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CARE
CARE
CDLX
CDLX
Operating Cash FlowLast quarter
$39.9M
$13.0M
Free Cash FlowOCF − Capex
$31.8M
$13.0M
FCF MarginFCF / Revenue
79.9%
25.5%
Capex IntensityCapex / Revenue
20.2%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$54.6M
$8.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CARE
CARE
CDLX
CDLX
Q4 25
$39.9M
$13.0M
Q3 25
$11.8M
$1.8M
Q2 25
$9.6M
$1.2M
Q1 25
$6.4M
$-6.7M
Q4 24
$36.9M
$3.0M
Q3 24
$10.3M
$1.4M
Q2 24
$-2.5M
$4.4M
Q1 24
$17.6M
$-17.6M
Free Cash Flow
CARE
CARE
CDLX
CDLX
Q4 25
$31.8M
$13.0M
Q3 25
$10.3M
$1.7M
Q2 25
$7.7M
$903.0K
Q1 25
$4.9M
$-6.8M
Q4 24
$28.8M
$2.9M
Q3 24
$8.4M
$878.0K
Q2 24
$-4.3M
$4.1M
Q1 24
$16.3M
$-18.3M
FCF Margin
CARE
CARE
CDLX
CDLX
Q4 25
79.9%
25.5%
Q3 25
26.3%
3.7%
Q2 25
20.6%
1.6%
Q1 25
13.1%
-12.1%
Q4 24
83.5%
4.2%
Q3 24
24.6%
1.4%
Q2 24
-12.7%
6.5%
Q1 24
48.8%
-29.4%
Capex Intensity
CARE
CARE
CDLX
CDLX
Q4 25
20.2%
0.0%
Q3 25
3.9%
0.0%
Q2 25
5.1%
0.6%
Q1 25
4.1%
0.2%
Q4 24
23.6%
0.2%
Q3 24
5.5%
0.8%
Q2 24
5.4%
0.4%
Q1 24
3.9%
1.0%
Cash Conversion
CARE
CARE
CDLX
CDLX
Q4 25
Q3 25
2.18×
Q2 25
1.13×
Q1 25
0.71×
Q4 24
Q3 24
1.83×
Q2 24
-0.51×
Q1 24
3.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons